Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOc2dJTF9ubExhMWNSWC05bUl3dXRpOFBXWG55cHZCRkQtUVczS1ZWTnM2dXpQeTdHdXV4MVJoLURBZEl5WHBoQ3NQT1YzTmVUeVlONXJ1N1dBNE5hTTdwNERqMnR4SlcwQ2RNYk9vQndlU3Y2ZEl0X0xBVUs3MDNJdnhwZk1KcThfNGFCbkp0VG0xQWFoOGhEbDlzUXVqSzRsaXB5d0N6bkpXemNaalhLeV81TzRNY1R2OWU2aUNQenppbGppMV9EVEdpSU9nMFF5WExMcQ?oc=5" target="_blank">Capricor shares skyrocket as FDA agrees to review new Duchenne drug data</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMUniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMNovo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro - reuters.com
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro reuters.com
September 29, 2026 at 09:49 PM